Immune response to E7 protein of human papillomavirus type 16 anchored on the cell surface
✍ Scribed by Šárka Němečková, Růžena Stránská, Jana Šubrtová, Luda Kutinová, Pavel Otáhal, Petr Hainz, Lucie Marešová, Vojtěch Šroller, Eva Hamšíková, Vladimír Vonka
- Publisher
- Springer-Verlag
- Year
- 2002
- Tongue
- English
- Weight
- 220 KB
- Volume
- 51
- Category
- Article
- ISSN
- 0340-7004
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract The serological response to human papillomavirus type 16 (HPV16) E6, E7, and L1 proteins was investigated in Italian patients with cervical cancer, cervical intraepithelial neoplasia (CIN), flat cervical warts, condylomas, and in healthy individuals. Bacterially expressed β‐galactosidas
## Abstract A synthetic peptide comprising amino acids 6‐35 of HPV‐16 E7 was used in an ELISA to screen sera taken from 31 cervical carcinoma patients. Sera obtained before and during treatment, and in follow‐up, were tested for the presence of antibodies to this peptide. Sixteen patients with nega
Expression of human papillomavirus type 16 (HPV 16) fusion proteins LI deltaCE7(1-55) and LI deltaCE7(1-60) (carboxy-terminal deletion of LI replaced by 55 or 60 amino-terminal amino acids of E7) leads to formation of chimeric papillomavirus-like particles (CVLPs). After "infection" of cells by CVLP
To analyze the antigenic properties of the human papillomavirus type 16 E7 oncoprotein, two monoclonal antibodies, VD6 and IB10, that have different reactivities to the E7 protein were generated. While the VD6 antibody reacted strongly with E7 protein in CaSki cell extracts, the other antibody, IB10